Le Lézard
Classified in: Health, Science and technology, Business
Subjects: FNC, TRI

China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMPK Activator Program


STOCKHOLM, Jan. 20, 2020 /PRNewswire/ -- Balticgruppen Bio, the Umeå based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has closed a funding round with China based asset management firm Ivy Capital granting the company 3 MUSD of funding.

Betagenon has successfully taken its first-in-class PAN-AMPK-activator O304, a novel small molecule for treatment of cardio-metabolic disorders, through pre-clinical and clinical Phase I and Phase IIa testing as well as long-term toxicological studies in animals. The results show that beneficial cardiovascular and metabolic effects observed in animal disease models translate to man, and that O304 is well tolerated in animals and in man. A recently developed new formulation of O304, based on discovery of a Na-derivative of O304 (O304X with IP priority date 2019), shows superior bioavailability and testing in man will start Q2 2020.

"The funding, as well as Ivy Capital's business network and connections within the Chinese Biotech and Pharmaceutical markets, will be important to support a speedy and global development of O304X in several major indications," says Thomas Edlund, CEO of Balticgruppen Bio AB and co-founder of the company.

Balticgruppen Bio AB/Betagenon is a privately owned Swedish Biotechnology company. Betagenon has received funding from EU's research and innovation framework program Horizon 2020 (EU project 754268 - AMPK-DIAB).

For more information, please contact:
Thomas Edlund, CEO Balticgruppen Bio AB
thomas.edlund@betagenon.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/betagenon-ab/r/china-based-ivy-capital-invests-in-betagenon-s-clinical-stage-ampk-activator-program,c3010550

The following files are available for download:

https://mb.cision.com/Main/9482/3010550/1175665.pdf

Press release (PDF)

 


These press releases may also interest you

at 20:00
Cybersecurity specialists hired by NCH recently wrapped up their investigation into an email phishing attack against NCH.  On or around June 14, 2019, NCH became aware of suspicious activity related to its human resources, timekeeping, and payroll...

at 19:40
The requirements to enroll in Charleston Real Estate School are as follows: You must be at least 18 years of age You must be a legal resident of the United States You must possess a high school diploma or a GED You must pass a criminal background...

at 19:25
Track Group, Inc. , a global leader in offender tracking and monitoring services, today announced financial results for its first quarter ended December 31, 2019 (the "First Quarter FY20"). The Company posted (i) revenue of $8.4M, an increase of 3%...

at 18:01
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spirit AeroSystems Holdings, Inc. between October 31, 2019 and January 29, 2020, inclusive (the "Class Period") of the important April 10, 2020 lead plaintiff...

at 18:00
The Global Animal feed protein ingredients market value is set to cross USD 220 billion by 2026, according to a new research report by Global Market Insights, Inc. Rising animal feed protein ingredients demand due to fostering agricultural business...

at 17:05
Otter Tail Corporation today announced financial results for the year ended December 31, 2019. 2019 Summary:     4Q19   4Q18   2019   2018 Operating Revenues (in millions)   $ 215.7   $ 221.2   $ 919.5  ...



News published on 19 january 2020 at 22:05 and distributed by: